{
  "id": 3641,
  "url": "https://nnemf.org/research/3641-results-of-temperature-controlled-radiofrequency-tissue-volume-reduction",
  "title": "Results of temperature-controlled radiofrequency tissue volume reduction for the turbinate hypertrophy.",
  "authors": [
    "Prakobkiat Hirunwiwatkul",
    "Songklot Aeumjaturapata",
    "Pornchai Oraphin"
  ],
  "journal": "Journal of the Medical Association of Thailand = Chotmaihet thangphaet",
  "year": "2004",
  "doi": null,
  "pmid": "16083169",
  "abstract": "OBJECTIVES: To assess the efficacy of temperature-controlled radiofrequency tissue volume reduction (RFTVR) for the inferior turbinate. RESEARCH DESIGNS: Prospective, single-blinded, experimental clinical trial. METHOD: Twenty patients with nasal obstruction secondary to inferior turbinate hypertrophy were enrolled. Nasal obstruction was compared between before and after the treatment (at 1-3 days, 1 week and 6-8 weeks) of RFTVR using subjective symptom scores, physical findings and videotape images. RESULTS: Improvement of nasal symptoms was observed as early as 1 week after the operation. However, significant improvement was obtained at 6-8 weeks. CONCLUSION: RFTVR for the turbinate may be useful as an alternative approach for the treatment of chronic turbinate hypertrophy.",
  "effect": "benefit",
  "evidence": "low",
  "extraction": {
    "studyType": "randomized_trial",
    "studyTypeLabel": "randomized trial",
    "effectDirection": "benefit",
    "evidenceLabel": "Low",
    "population": "Patients with nasal obstruction secondary to inferior turbinate hypertrophy",
    "sampleSize": "20",
    "exposure": "RF",
    "confidencePct": "74",
    "peerReviewed": "yes",
    "mainFindings": "Nasal symptom improvement was observed as early as 1 week after radiofrequency tissue volume reduction, with significant improvement at 6–8 weeks post-treatment.",
    "outcomes": [
      "Nasal obstruction/nasal symptoms (subjective symptom scores)",
      "Physical findings",
      "Videotape image assessment"
    ],
    "limitations": [
      "Small sample size (n=20)",
      "Single-blinded design",
      "Follow-up limited to 6–8 weeks",
      "No RF exposure parameters (e.g.",
      "frequency",
      "dose) reported in abstract"
    ],
    "keywords": [
      "radiofrequency",
      "temperature-controlled",
      "tissue volume reduction",
      "inferior turbinate",
      "turbinate hypertrophy",
      "nasal obstruction",
      "clinical trial"
    ],
    "hubs": [],
    "raw": "{\n  \"study_type\": \"randomized_trial\",\n  \"exposure\": {\n    \"band\": \"RF\",\n    \"source\": \"medical procedure (radiofrequency tissue volume reduction)\",\n    \"frequency_mhz\": null,\n    \"sar_wkg\": null,\n    \"duration\": null\n  },\n  \"population\": \"Patients with nasal obstruction secondary to inferior turbinate hypertrophy\",\n  \"sample_size\": 20,\n  \"outcomes\": [\n    \"Nasal obstruction/nasal symptoms (subjective symptom scores)\",\n    \"Physical findings\",\n    \"Videotape image assessment\"\n  ],\n  \"main_findings\": \"Nasal symptom improvement was observed as early as 1 week after radiofrequency tissue volume reduction, with significant improvement at 6–8 weeks post-treatment.\",\n  \"effect_direction\": \"benefit\",\n  \"limitations\": [\n    \"Small sample size (n=20)\",\n    \"Single-blinded design\",\n    \"Follow-up limited to 6–8 weeks\",\n    \"No RF exposure parameters (e.g., frequency, dose) reported in abstract\"\n  ],\n  \"evidence_strength\": \"low\",\n  \"confidence\": 0.74,\n  \"peer_reviewed_likely\": \"yes\",\n  \"keywords\": [\n    \"radiofrequency\",\n    \"temperature-controlled\",\n    \"tissue volume reduction\",\n    \"inferior turbinate\",\n    \"turbinate hypertrophy\",\n    \"nasal obstruction\",\n    \"clinical trial\"\n  ],\n  \"suggested_hubs\": []\n}"
  },
  "synthesis": null,
  "synthesisStatus": "pending",
  "originalHref": "https://pubmed.ncbi.nlm.nih.gov/16083169/",
  "sourceUrl": "https://rfsafe.org/mel/paper.php?id=3641",
  "updated": "2026-02-13 07:31:22"
}